A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Authors
Keywords
Urine, Cancer treatment, Toxicity, Amines, Metabolites, Pharmacokinetics, Creatinine, Drug metabolism
Journal
PLoS One
Volume 10, Issue 5, Pages e0127246
Publisher
Public Library of Science (PLoS)
Online
2015-05-28
DOI
10.1371/journal.pone.0127246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polyamine blockade promotes antitumor immunity
- (2014) Candace S Hayes et al. OncoImmunology
- Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation
- (2013) Ingo Lange et al. JOURNAL OF MOLECULAR BIOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
- (2013) Nathan J. Robison et al. PEDIATRIC BLOOD & CANCER
- Unbiased Metabolite Profiling Indicates That a Diminished Thymidine Pool Is the Underlying Mechanism of Colon Cancer Chemoprevention by Alpha-Difluoromethylornithine
- (2013) M. Witherspoon et al. Cancer Discovery
- Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the Congo
- (2012) Emilie Alirol et al. CLINICAL INFECTIOUS DISEASES
- Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
- (2012) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
- Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
- (2012) Laura D. Gamble et al. Frontiers in Oncology
- The mechanisms by which polyamines accelerate tumor spread
- (2011) Kuniyasu Soda JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract
- (2010) Takeshi Uemura et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of -Difluoromethylornithine in Subjects with Previous History of Skin Cancer
- (2010) H. H. Bailey et al. Cancer Prevention Research
- Neuroblastoma: Therapeutic strategies for a clinical enigma
- (2010) Shakeel Modak et al. CANCER TREATMENT REVIEWS
- Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal Adenoma
- (2010) Patricia A. Thompson et al. GASTROENTEROLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
- (2009) R. J. Rounbehler et al. CANCER RESEARCH
- Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
- (2009) N. F. Evageliou et al. CLINICAL CANCER RESEARCH
- Associations of a Polymorphism in the Ornithine Decarboxylase Gene with Colorectal Cancer Survival
- (2009) J. A. Zell et al. CLINICAL CANCER RESEARCH
- Genetic polymorphism in ornithine decarboxylase and risk of breast cancer
- (2009) Iain Brown et al. Familial Cancer
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
- (2009) Gerardo Priotto et al. LANCET
- Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
- (2008) Frank L. Meyskens et al. Cancer Prevention Research
- Ornithine Decarboxylase Inhibition by -Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
- (2008) D.-L. T. Koomoa et al. CANCER RESEARCH
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
- (2008) M. D. Hogarty et al. CANCER RESEARCH
- Medical treatment of hirsutism
- (2008) Ulrike Blume-Peytavi et al. Dermatologic Therapy
- Identification and Characterization of a Diamine Exporter in Colon Epithelial Cells
- (2008) Takeshi Uemura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started